ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $895,349 | -30.5% | 32,990 | -21.3% | 0.01% | -41.2% |
| Q2 2023 | $1,288,160 | +94.5% | 41,905 | +127.9% | 0.02% | +88.9% |
| Q1 2023 | $662,376 | -47.9% | 18,384 | -42.9% | 0.01% | -55.0% |
| Q4 2022 | $1,271,833 | -7.3% | 32,182 | -52.9% | 0.02% | +25.0% |
| Q3 2022 | $1,372,371 | +266.0% | 68,256 | +665.8% | 0.02% | +128.6% |
| Q2 2022 | $375,000 | -79.3% | 8,913 | -80.8% | 0.01% | -68.2% |
| Q1 2022 | $1,808,000 | +146.3% | 46,413 | +128.6% | 0.02% | +266.7% |
| Q3 2021 | $734,000 | -45.8% | 20,299 | -38.5% | 0.01% | -50.0% |
| Q2 2021 | $1,353,000 | +430.6% | 33,000 | +463.7% | 0.01% | +300.0% |
| Q1 2021 | $255,000 | – | 5,854 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |